Site Members can sign up for company wide alerts
Lawsuit Overview
Sept. 28, 2012 (Shareholders Foundation) -- An investor in shares of Medicis Pharmaceutical Corp (NYSE:MRX) filed a lawsuit against directors in effort to stop the proposed takeover at $44.00 per NYSE:MRX share. On September 3, 2012, Valeant Pharmaceuticals International, Inc. and Medicis Pharmaceutical Corporation announced that they have entered into an agreement under which Valea...
You must register (for free) or login to view the entire case.